Search Results

An Interview With Krishna Rocha-Singh, MD

A leading interventional cardiologist and clinical trialist discusses new advancements in vascular therapy and his thoughts on the emerging trial data.

The DURABILITY II Trial

Krishna Rocha-Singh, MD, FACC, FSCAI, discusses the current status of the DURABILITY II trial, a challenging landmark study of patency and fracture resistance of stenting in the superficial femoral and popliteal arteries.

Setting the Stage for Future Lower-Extremity Device Trials

Krishna Rocha-Singh, MD, of VIVA Physicians, Inc., discusses their effort to determine nitinol stenting performance goals, collaboration with the FDA and industry, and how clinicians can apply these standards to their practices.

By Krishna Rocha-Singh, MD

DURABILITY II Trial

A new standard in femoropopliteal artery nitinol stent trial design.

By Krishna Rocha-Singh, MD, FACC, FSCAI, FSVM

Bare Nitinol Stenting of Tibial Arteries in CLI Patients

An interim look the VIVA I/XCELL trial.

By Krishna Rocha-Singh, MD, FACC, FSCAI, on behalf of VIVA Physicians, Inc.

Interim Results From the VIVA I: Xcell Trial

Bare-nitinol stenting of tibial arteries and wound-healing assessment in critical limb ischemia patients.

By Krishna Rocha-Singh, MD, FACC, on behalf of VIVA Physicians, Inc.

Challenges Facing Current and Next-Generation SFA Technologies

A discussion of anatomic barriers to treatment, evolving trial designs, and the impact of reimbursement.

By Krishna Rocha-Singh, MD

The Challenges of Calcium in Peripheral Artery Disease

Dr. Rocha-Singh discusses the available methods for calcium assessment and scoring, how calcium affects procedural success, and the goals of the VIVA calcium scoring unification initiative.

With Krishna Rocha-Singh, MD

Ask the Experts: What SFA Trials Would You Most Like to See?

Experts discuss key questions to answer, potential trial designs, and the likelihood that the trials will be undertaken.

With Peter A. Schneider, MD; Thomas Zeller, MD; Osamu Iida, MD; Marianne Brodmann, MD; Krishna Rocha-Singh, MD; and Christopher Metzger, MD

Highlights From ISET